Author

José Ignacio Martín Valadés

Observed names: J. Martin Valades, J. Martín Valadés, Jose Ignacio Martin Valades, Jose Ignacio Martin Valadés, Jose Ignacio Martín Valadés, José Martín Valadés

Institution: MD Anderson Cancer Center Madrid

Observed institutions: Universitat Autònoma de Barcelona, Institut Gustave Roussy, Hospital Son Llatzer, Hospital de Basurto, Vall d'Hebron Hospital Universitari, Hospital Universitario Fundación Jiménez Díaz, Hospital General de Elda, Hospital Universitario Virgen de la Arrixaca, MD Anderson Cancer Center Madrid, Hospital Universitario de Jerez, Fondation Gustave Roussy

ORCID: 0000-0001-7720-8713

Observed ORCID: 0000-0001-7720-8713

OpenAlex ID: A5063480696

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2

2018 · Teresa Macarulla, Roberto Pazo-Cid, et al. · Journal of Clinical Oncology · 95

Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives?

2017 · Delia Cortes-Guiral, Dominique Elias, et al. · World Journal of Gastroenterology · 20

PDF

Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in Spain

2025 · Rafael Álvarez-Gallego, Roberto Pazo-Cid, et al. · Therapeutic Advances in Medical Oncology · 6

Clinical outcomes of FOLFIRINOX and gemcitabine-nab-paclitaxel for metastatic pancreatic cancer in the real-world setting.

2020 · Fabio Franco, Jose Ignacio Martin Valades, et al. · Journal of Clinical Oncology · 6

Clinical outcomes of FOLFIRINOX and gemcitabine/nab-paclitaxel in the real world setting.

2018 · Fernando Franco Franco, Camara Juan C, et al. · Journal of Clinical Oncology · 2

Role of c-MET pathway in the outcome prediction of cetuximab-based therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

2012 · Victoria Casado, Juan Luis Arranz, et al. · Journal of Clinical Oncology · 2

Observational transversal study to relate functional status and age with the doublet or triplet chemotherapy based on capecitabine in advanced gastric cancer patients.

2011 · B. Martinez Amores, M. Alsina, et al. · Journal of Clinical Oncology · 1

P-182 Multicenter real-world data of treatment with NALIRI plus 5FU/LV in advanced Spanish pancreatic cancer

2023 · R. Álvarez Gallego, R. Pazo Cid, et al. · Annals of Oncology

PDF

Implementation of a PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy) protocol in a monographic Oncology Center.

2022 · Santiago Gonzalez-Moreno, Irene Lopez Rojo, et al. · European Journal of Surgical Oncology

Activity of aflibercept (Afli) in combination with FOLFIRI (F) for patients with metastatic colorectal cancer (mCRC) in a real-life setting in Spain: Final results of the retrospective study Named Patient Program.

2016 · Javier Sastre, Jaime Feliu, et al. · Journal of Clinical Oncology

Analysis of patients with locally advanced NSCLC after induction therapy: Importance of nodal downstaging, and prognostic factors for survival.

2014 · Jose Antonio Lopez-Vilariño, Manuel Domine, et al. · Journal of Clinical Oncology

Cáncer de mama en un varón. A propósito de un caso

2008 · Cristina Mora Casado, Mónica Sánchez-Montero Martínez-Piqueras, et al. · FMC - Formación Médica Continuada en Atención Primaria

Works count: 12

Citation count: 132

H-index: 4

I10-index: 2